ArticleMolecular therapy. Methods & clinical development2020

Targeting the Root Cause of Mucopolysaccharidosis IIIA with a New scAAV9 Gene Replacement Vector.

Tierra A Bobo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.